UiPath Inc.

NYSE:PATH Stock Report

Market Cap: US$8.5b

UiPath Valuation

Is PATH undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

0/6

Valuation Score 0/6

Share Price vs Fair Value

What is the Fair Price of PATH when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

US$17.84
Fair Value
13.5% undervalued intrinsic discount
13
Number of Analysts


Key Valuation Metric

Which metric is best to use when looking at relative valuation for PATH?

Key metric:

The above table shows the Price to Sales ratio for PATH. This is calculated by dividing PATH's market cap by their current revenue.
What is PATH's PS Ratio?
PS Ratio5.5x
SalesUS$1.50b
Market CapUS$8.46b

Price to Sales Ratio vs Peers

How does PATH's PS Ratio compare to its peers?

The above table shows the PS ratio for PATH vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PSEstimated GrowthMarket Cap
Peer Average10.3x
CVLT Commvault Systems
7.2x11.31%US$7.6b
VRNS Varonis Systems
11.4x13.41%US$6.8b
NTSK Netskope
14.2x19.34%US$8.7b
MNDY monday.com
8.3x17.46%US$9.1b
PATH UiPath
5.7x8.34%US$8.9b


Price to Sales Ratio vs Industry

How does PATH's PS Ratio compare vs other companies in the US Software Industry?

87 CompaniesPrice / SalesEstimated GrowthMarket Cap
RNG RingCentral
1x4.83%US$2.42b
TDC Teradata
1.2x-0.58%US$2.01b
VYX NCR Voyix
0.6x-13.01%US$1.63b
VRNT Verint Systems
1.4x7.13%US$1.22b
PATH 5.5xIndustry Avg. 4.9xNo. of Companies87PS0612182430+
87 CompaniesEstimated GrowthMarket Cap
No more companies


Price to Sales Ratio vs Fair Ratio

What is PATH's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

PATH PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio5.5x
Fair PS Ratio6.9x


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

US$13.44
Fair Value
14.9% overvalued intrinsic discount
13
Number of Analysts


Discover undervalued companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/10/17 21:58
End of Day Share Price 2025/10/17 00:00
Earnings2025/07/31
Annual Earnings2025/01/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

UiPath Inc. is covered by 29 analysts. 19 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Raimo LenschowBarclays
William Kingsley CraneBerenberg
Keith BachmanBMO Capital Markets Equity Research